PureTech Health plc (PTCHF PINK) stock market data APIs
$1.5952
0(0%)
as of July 17, 2026
Try our APIs with
free plan!
PureTech Health plc Financial Data Overview
Price chart is built with
Anychart
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage. PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts.
Prev. Close
1.5952
Open
1.5952
High
1.5952
Low
1.5952
52 wk Range
1.55-1.92
Market Cap
438 M
Shares Outstanding
243 M
Revenue
4 659 K
EPS
-0.1318
Beta
0.793
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PureTech Health plc data using free add-ons & libraries
Get PureTech Health plc Fundamental Data
PureTech Health plc Fundamental data includes:
- Net Revenue: 4 659 K
- EBITDA: -96 830 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PureTech Health plc News
New
PureTech Health plc reports 1H results
* PureTech Health plc press release [https://seekingalpha.com/pr/20214107-puretech-health-plc-half-year-report] (OTC:PTCHF [https://seekingalpha.com/symbol/PTCHF]): 1H ~$320M PureTech level cash, cas...
PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases
Former Teva North America CEO Sven Dethlefs, PhD, to lead Celea BOSTON, August 12, 2025--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage...
PureTech Health announces CEO transition
* Clinical-stage biotherapeutics company PureTech Health (NASDAQ:PRTC [https://seekingalpha.com/symbol/PRTC]) said that [https://seekingalpha.com/pr/20167285-puretech-announces-leadership-transition...
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference
BOSTON, January 03, 2024--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of pati...
Get PureTech Health plc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
